I have been running TB-500 for five years and the honest summary is that the effect is smaller than the internet suggests and real.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Where does the human data stop and the extrapolation begin? That is the whole thread.
Baseline first. Without a baseline the after picture is decoration.
Stupid question: how do you know whether what is in the vial matches the label at all?
Nobody has ever been talked out of a stack by a stranger on the internet.
Same here.
Five years in on TB-500 and it lines up.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Baseline first.
Baseline first. Without a baseline the after picture is decoration.
Is a baseline blood test really necessary before starting something like this?
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.